Pharmosa Biopharm Inc.;Pharmosa Therapeutics, Inc.
发明人:
Pei KAN,Yi Fong LIN,Ko Chieh CHEN
申请号：
US16404272
公开号：
US20190336461A1
申请日:
2019.05.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided herein are pharmaceutical compositions containing (a) at least one liposome includes at least one vesicle-forming phospholipid； and (b) treprostinil encapsulated within the liposome. The ratio of treprostinil to phospholipid is equal to or higher than 0.035 and provides a controlled release of treprostinil. Also provided is the use of the pharmaceutical compositions to treat respiratory diseases.
